The Playground

  • Since this is the playground let's play a guessing game of where this quote came from:


    "DTP was associated with 5-fold higher mortality than being unvaccinated. No prospective study has shown beneficial survival effects of DTP. Unfortunately, DTP is the most widely used vaccine, and the proportion who receives DTP3 is used globally as an indicator of the performance of national vaccination programs. It should be of concern that the effect of routine vaccinations on all-cause mortality was not tested in randomized trials. All currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis. Though a vaccine protects children against the target disease it may simultaneously increase susceptibility to unrelated infections.

    The recently published SAGE review called for randomized trials of DTP (Higgins et al., 2014). However, at the same time the IVIR-AC committee to which SAGE delegated the follow-up studies of the NSEs of vaccines has indicated that it will not be possible to examine the effect of DTP in an unbiased way. If that decision by IVIR-AC remains unchallenged, the present study may remain the closest we will ever come to a RCT of the NSEs of DTP."


    DTP = Diphtheria-Tetanus-Pertussis vaccination

  • I'm a doctor and a Democrat, and I won't let the mob force me to choose between the two

    I used to view Democrats as champions of free speech


    I'm a doctor and a Democrat, and I won't let the mob force me to choose between the two
    Medical professionals who refuse to toe the party line risk censorship, cancellation, and even the loss of license—a fate far worse than getting banned from…
    www.foxnews.com


    The trend is forcing doctors who exhibit critical thinking to face an existential choice: join the mob and support what many of us believe are dangerous policies without a sound scientific basis, or stand up and risk losing your livelihood.


    This trend has troubling long-term implications for patients—something all of us will become at some point in our lives.

  • Neuropathic symptoms with SARS-CoV-2 vaccination


    Neuropathic symptoms with SARS-CoV-2 vaccination
    Background and Objectives Various peripheral neuropathies, particularly those with sensory and autonomic dysfunction may occur during or shortly after acute…
    www.medrxiv.org


    Abstract

    Background and Objectives Various peripheral neuropathies, particularly those with sensory and autonomic dysfunction may occur during or shortly after acute COVID-19 illnesses. These appear most likely to reflect immune dysregulation. If similar manifestations can occur with the vaccination remains unknown.


    Results In an observational study, we studied 23 patients (92% female; median age 40years) reporting new neuropathic symptoms beginning within 1 month after SARS-CoV-2 vaccination. 100% reported sensory symptoms comprising severe face and/or limb paresthesias, and 61% had orthostasis, heat intolerance and palpitations. Autonomic testing in 12 identified seven with reduced distal sweat production and six with positional orthostatic tachycardia syndrome. Among 16 with lower-leg skin biopsies, 31% had diagnostic/subthreshold epidermal neurite densities (≤5%), 13% were borderline (5.01-10%) and 19% showed abnormal axonal swelling. Biopsies from randomly selected five patients that were evaluated for immune complexes showed deposition of complement C4d in endothelial cells. Electrodiagnostic test results were normal in 94% (16/17). Together, 52% (12/23) of patients had objective evidence of small-fiber peripheral neuropathy. 58% patients (7/12) treated with oral corticosteroids had complete or near-complete improvement after two weeks as compared to 9% (1/11) of patients who did not receive immunotherapy having full recovery at 12 weeks. At 5-9 months post-symptom onset, 3 non-recovering patients received intravenous immunoglobulin with symptom resolution within two weeks.


    Conclusions This observational study suggests that a variety of neuropathic symptoms may manifest after SARS-CoV-2 vaccinations and in some patients might be an immune-mediated process.


    What is the core finding?

    The study’s findings establish some evidence, which must be validated via peer review and probably additional study, that COVID-19 vaccination can lead to, at least in some people, dysimmune neuropathy. The authors posit, “The fact that participants were screened, and common causes of neuropathy eliminated, the presence of oligoclonal bands in the CSF of two of five participants, deposition of immune complexes on skin biopsy and apparent response to immunotherapy supports possible immune involvement.”


    100% of the participants reported sensory symptoms comprising severe face and/or limb paresthesia, and 61% had orthostasis, heat intolerance, and palpitations. Autonomic testing in 12 identified seven with reduced distal sweat production and six with positional orthostatic tachycardia syndrome.


    Sixteen of the participants had lower-leg skin biopsies—31% of these had diagnostic/subthreshold epidermal neurite densities (≤5%), 13% were borderline (5.01-10%) and 19% showed abnormal axonal swelling.


    Among 16 with lower-leg skin biopsies, 31% had biopsies from randomly selected five patients that were evaluated for immune complexes showed deposition of complement C4d in endothelial cells. Electrodiagnostic test results were normal in 94% (16/17). Together, 52% (12/23) of patients had objective evidence of small-fiber peripheral neuropathy. 58% patients (7/12) treated with oral corticosteroids had complete or near-complete improvement after two weeks as compared to 9% (1/11) of patients who did not receive immunotherapy having full recovery at 12 weeks. At 5-9 months post-symptom onset, 3 non-recovering patients received intravenous immunoglobulin with symptom resolution within two weeks.

  • External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • Monkeypox: why scientists are on alert

    More than 120 confirmed or suspected cases of monkeypox, a chickenpox-like infection, have been reported in at least 11 non-African countries, including the United Kingdom, the United States and Spain, in the past week. The disease is very rare and is most often found in West or Central Africa. The emergence of the virus in separate populations across the world in places where it doesn’t usually appear has alarmed scientists — and sent them racing for answers. Any new viral behaviour is worrying, but researchers are not panicked: the disease is generally mild, most people recover in a few weeks without treatment and monkeypox is vulnerable to vaccines and treatments that were developed for smallpox.


    Nature | 6 min read

  • FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

    FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox
    FDA announced approval of Jynneos for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk
    www.fda.gov


    The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. This is the only currently FDA-approved vaccine for the prevention of monkeypox disease.

  • The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.

    What a happy coincidence.........

  • Vietnam Vet Versus Fermi Labs.

    3:40 minute mark.


    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • What a happy coincidence.........

    They're prescient. First, the FDA approving a monkeypox/smallpox vaccine in 2019. Then in 2021 the NTI people do a tabletop simulation of a Monkeypox attack occurring on May 15 2022. (page 10)


    https://www.nti.org/wp-content/uploads/2021/11/NTI_Paper_BIO-TTX_Final.pdf


    It reminds me of the Event 201 simulation of a Corovavirus outbreak done in 2019 which as we know so soon came to pass.


    Pandemic simulation exercise spotlights massive preparedness gap
    Event 201 simulation hosted by university's Center for Health Security envisions a fast-spreading coronavirus with a devastating impact
    hub.jhu.edu


    They are that good. Rest assured, we're safe.

  • I'm curious if these US Army assessment reports have been posted here already? Gotta appreciate what else might be in the government attic.


    The Government Attic folks obtained them though a 'Freedom of Information Act' filing. Fifty pages discussing everything from the ECat to nuclear. theory.


    I am impressed with the refence list. I plan to review all of them.



    Source
    governmentattic.org was first indexed by Google more than 10 years ago

    This responds to your Freedom of Information Act (FOIA) request of August 4, 2016,

    requesting a copy of records such as assessments, foreign technology reports and memos concerning Low Energy Nuclear Reaction (LENR) between 2004 to present and supplements our response of August 10, 2016.

    We have completed a mandatory declassification review in accordance with Executive Order (EO) 13526. As a result of this review, information has been sanitized as it is currently and

    properly classified SECRET according to Sections 1.2 (a)(2), 1.4(c) and 1.4(e), and of EO 13526.

    This information is exempt from the public disclosure provisions of the FOIA pursuant to Title 5 U.S. Code 552 (b)(1). A brief explanation of the applicable sections follows:

    Section 1.2(a)(2) of EO 13526, provides that information shall be classified SECRET if its unauthorized disclosure reasonably could be expected to cause serious damage to the national security

    Section 1.4(c) of EO 13526, provides that information pertaining to intelligence activities, intelligence sources or methods, and cryptologic information shall be considered for classification protection.

    Section 1.4(e) of EO 13526, provides that information pertaining to scientific, technological or economic matters relating to national security which includes defense against transnational

    terrorism shall be considered for classification protection.

    The deleted information is also exempt from automatic declassification in accordance with EO 13526, Section 3.3(b)(1) because its release would clearly and demonstrably be expected to

    reveal the identity of a confidential human source, a human intelligence source, a relationship with an intelligence or security service of a foreign government or international organization, or a nonhuman intelligence source; or impair the effectiveness of an intelligence method currently in

    use, available for use, or under development.

    Information has been sanitized according to Title 5 U.S.Code 552 (b)(3) the statute invoked is 50 U.S.C. § 3024(i), which allows for the protection of intelligence sources and methods.

    In addition, information has been sanitized as the release of the information would result in an

    unwarranted invasion of the privacy rights of the individuals concerned, this information is exempt from public disclosure provisions of the FOIA pursuant to Title 5 U.S. Code 552 (b)(6).

  • Kory mentions a new Ivermectin study out "yesterday" which would have been May 18th. Can't find it though.

  • Kory mentions a new Ivermectin study out "yesterday" which would have been May 18th. Can't find it though.

    Around 8:10 of the video, the host says a "white paper" was "dropped last night".

    Kory then says "they reviewed dozens of randomized trials", which indicates it was a meta analysis of previous studies. I thought it may be an update to https://ivmmeta.com but I see that was last updated in April, hmmm.

  • Don't know it its in small releases to keep and eye on it over 50 years or just the Wormwood story

    External Content www.youtube.com
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • Stay away from radioactive sushi which will be inevitable from this release of radioactive waste!

    Do once the calculation... How much water is in the pacific and in the Fukushima tanks.

    If done properly nobody will notice the increase in radioactivity.


    There is a sheep farming hill in south England that still delivers radioactive meet from Tschernobyl.

    Solution: Let the sheep live 6 weeks on uncontaminated ground and 137-Cs is gone. It is as mobile as Sodium...